Market Highlights

• Overall vacancy increased by 180 basis points (bps) to 23.9%, up from 22.1% in Q3 2024.
• Raleigh-Durham has had no active life sciences construction for more than a year, as developers have abandoned or deferred projects amid prolonged weakness.
• Raleigh-Durham has raised $814.5 million in venture capital year to date, nearly matching 2024’s full-year total of $883.1 million and positioning 2025 to be one of its strongest years.

Read the full report